tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Ian Somaiya, 85 are a BUY (76.58%), 26 are a HOLD (23.42%).
Analyst Ian Somaiya, carries an average stock price target met ratio of 66.09% that have a potential upside of 38.83% achieved within 628 days. Previously, Ian Somaiya worked at BMO, NOMURA.
Ian Somaiya’s has documented 225 price targets and ratings displayed on 15 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on AGLE, Aeglea Bio Therapeutics at 14-Mar-2018.
Analyst best performing recommendations are on INFI (INFINITY PHARMACEUTICALS).
The best stock recommendation documented was for INFI (INFINITY PHARMACEUTICALS) at 5/7/2015. The price target of $13 was fulfilled within 1 day with a profit of $0.35 (2.77%) receiving and performance score of 27.67.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-Jul-2017
$205
$22.5 (12.33%)
5 years 6 months 7 days ago
(05-May-2021)
3/5 (60%)
$35.09 (20.65%)
938
Hold Since 03-May-2021
$173
$-9.5 (-5.21%)
$156
5 years 6 months 9 days ago
(03-May-2021)
18/29 (62.07%)
$2.73 (1.60%)
667
Hold Since 04-Feb-2021
$190
$7.5 (4.11%)
$190
5 years 6 months 17 days ago
(26-Apr-2021)
11/14 (78.57%)
$23 (13.77%)
420
Buy Since 06-Sep-2019
$175
$-7.5 (-4.11%)
$165
5 years 9 months 8 days ago
(04-Feb-2021)
3/3 (100%)
$19.41 (12.48%)
397
Buy Since 08-Feb-2018
$166
$-16.5 (-9.04%)
$179
5 years 9 months 8 days ago
(04-Feb-2021)
21/21 (100%)
$10.41 (6.69%)
711
